title: A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck.
authors.forename: M
authors.initials: M
authors.lastname: Degardin
authors.forename: C
authors.initials: C
authors.lastname: Domenge
authors.forename: P
authors.initials: P
authors.lastname: Cappelaere
authors.forename: B
authors.initials: B
authors.lastname: Luboinski
authors.forename: M S
authors.initials: MS
authors.lastname: Navarrete
authors.forename: J E
authors.initials: JE
authors.lastname: Scott
authors.forename: J L
authors.initials: JL
authors.lastname: Lefebvre
mesh_terms: D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D011743:Pyrimidines; C024530:piritrexim